NKTR

Conviction 58HealthcareScan · Mon, Aug 10, 2026

Bearish harami

NKTR$74.78-2.22%

ResistanceSupportVol 14Insider sell

Vol MA14 763.54K

May 11May 28Jun 16Jul 6Jul 23Aug 10

NEKTAR THERAPEUTICSPHARMACEUTICAL PREPARATIONSwww.nektar.com ↗

Price74.78

Change-2.22%

Gap-0.59%

Rel volume2.55×

Avg volume768.73K

Avg $ vol54.39M

SMA 2070.49

SMA 5066.59

SMA 20063.49

Price vs 50+12.30%

Price vs 200+17.79%

MA stackbullish

50/200 cross—

Supertrendup · 66.01

RSI (14)61

MACD hist0.45

MACD cross—

Stoch %K / %D78 / 89

ADX (14)12

+DI / −DI25 / 16

RSI divergence—

MACD divergence—

ATR %+4.36%

ADR %4.47%

52w high100.35

52w low22.47

From 52w high-25.48%

Above 52w low+232.80%

New 52w highNo

SqueezeOff

Bollinger width15.40%

%B0.90

Donchian pos82.60%

Donchian high77.00

Donchian low64.24

AVWAP (52w high)73.43

vs AVWAP high+1.84%

AVWAP (52w low)60.99

vs AVWAP low+22.61%

OBV trendFlat

Chaikin MF (20)0.09

Today vs 20d2.55×

Avg vol (14d)763.54K

Avg vol (20d)768.73K

Avg $ vol (20d)54.39M

Market cap2.53B

RS 3m (vs SPY)-13.96%

RS 6m (vs SPY)+103.65%

RS line new highNo

Trend template6/8

Technical rank87.0

1 week+5.94%

1 month+6.28%

3 months-8.68%

6 months+103.15%

1 year+243.82%

YTD+72.22%

P/E-15.40

P/B4.38

P/S45.74

P/FCF-12.11

EPS-9.73

Div yield—

ROE-28.47%

ROA-21.50%

Debt/Eq0.23

Current10.21

EV/EBITDA-18.46

Gross margin1.13%

Net margin-297.07%

Rev growth-43.89%

EPS growth-37.92%

Price target149.40

Target upside99.79%

Analyst ratingBuy

Institutional93.44%

Ent. value2.51B

Revenue10.86M

Net income-44.9M

Gross profit—

Free cash flow-208.68M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out33.79M

Employees63

ListedTue, May 3, 1994

Free float28.9M

Float %97.4%

Short interest6.82M

Days to cover7.0d

Short volume49.8%

Squeeze score87 / 100

Next earningsThu, Aug 13, 2026 · after (3d)

EPS forecast−$1.94 · 6 est

Last EPS vs est−$1.82 vs −$1.74

Last surprise-4.6% miss

Setup gradeC

Conviction58 / 100

Pattern quality—

Tech rank87.0 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NKTR

All disclosures →

No recent disclosed trades by Congress in NKTR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NKTR · 6 sells

Insider	Side	Shares	Value	Traded	Filed
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-17	Sell	4.5K	$277K	2026-06-17	2026-06-18
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-17	Sell	5.5K	$334K	2026-06-17	2026-06-18
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-16	Sell	5.3K	$318K	2026-06-16	2026-06-18
ROBIN HOWARD W President & CEO · Common Stock · 2026-06-16	Sell	4.7K	$285K	2026-06-16	2026-06-18
Zalevsky Jonathan Chief R&D Officer · Common Stock · 2026-05-19	Sell	199	$13K	2026-05-19	2026-05-21
ROBIN HOWARD W President & CEO · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
ROBIN HOWARD W President & CEO · Common Stock · 2026-05-19	Sell	444	$29K	2026-05-19	2026-05-21

SEC filings

EDGAR filings in NKTR · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.